256.56
price down icon12.26%   -35.86
after-market After Hours: 256.56
loading
Bio Rad Laboratories Inc stock is traded at $256.56, with a volume of 1.06M. It is down -12.26% in the last 24 hours and down -20.37% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$292.42
Open:
$251
24h Volume:
1.06M
Relative Volume:
5.09
Market Cap:
$6.92B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-9.3875
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-14.91%
1M Performance:
-20.37%
6M Performance:
-10.66%
1Y Performance:
-16.26%
1-Day Range:
Value
$251.00
$272.79
1-Week Range:
Value
$251.00
$301.47
52-Week Range:
Value
$211.43
$343.12

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name
Name
Bio Rad Laboratories Inc
Name
Phone
(510) 724-7000
Name
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Name
Employee
7,700
Name
Twitter
@BioRadLifeSci
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
BIO's Discussions on Twitter

Compare BIO vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
BIO
Bio Rad Laboratories Inc
256.56 7.89B 2.58B -778.69M 223.75M -27.33
Medical Devices icon
ABT
Abbott Laboratories
112.68 193.83B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
366.05 140.01B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
99.49 129.33B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
BSX
Boston Scientific Corp
74.73 109.92B 20.08B 2.89B 3.82B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
75.87 44.36B 6.07B 1.06B 799.60M 1.8527

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-01-24 Upgrade Citigroup Neutral → Buy
Aug-28-24 Initiated Wells Fargo Equal Weight
Jun-03-24 Resumed Jefferies Hold
Apr-03-24 Downgrade Citigroup Buy → Neutral
Dec-07-23 Initiated UBS Buy
Jun-16-23 Initiated Wells Fargo Overweight
Dec-07-22 Initiated RBC Capital Mkts Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Jan-28-22 Reiterated Citigroup Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Oct-17-18 Initiated Goldman Buy
Sep-20-18 Initiated Morgan Stanley Equal-Weight
Feb-16-18 Downgrade CL King Buy → Neutral
Jul-13-17 Initiated Wells Fargo Outperform
Jun-28-17 Upgrade Deutsche Bank Hold → Buy
Jan-18-17 Initiated Deutsche Bank Hold
Oct-13-16 Initiated CL King Buy
May-06-15 Reiterated Jefferies Buy
Dec-18-09 Initiated Maxim Group Buy
Nov-06-09 Initiated Jefferies & Co Buy
Jul-17-09 Initiated Soleil Buy
Sep-26-07 Initiated Banc of America Sec Buy
Feb-23-07 Downgrade Robert W. Baird Outperform → Neutral
View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

pulisher
01:45 AM

Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat

01:45 AM
pulisher
12:53 PM

Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus

12:53 PM
pulisher
Feb 13, 2026

Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad Laboratories Inc (BIO) Shares Down 11.17% on Feb 13 - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Oversold Conditions For Bio-Rad Laboratories (BIO) - Nasdaq

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA - Nasdaq

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

S&P 500 Futures Drop in Premarket Trading; Pinterest, Bio-Rad Labs A Lag - Barron's

Feb 13, 2026
pulisher
Feb 13, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad Laboratories, Inc. $BIO Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements - MSN

Feb 13, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories Q4 2025 Earnings Call Transcript - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories Q4 Earnings Call Highlights - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts By Investing.com - Investing.com South Africa

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad (BIO) Q4 2025 Earnings Call Transcript - AOL.com

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad: Q4 Earnings Snapshot - kare11.com

Feb 12, 2026
pulisher
Feb 12, 2026

BIO: 2025 results met guidance with diagnostics growth, ddPCR momentum, and cautious 2026 outlook - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

BIO: 2025 saw resilient revenue and cash flow, with diagnostics growth and ddPCR momentum offsetting margin pressures - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations - Investing.com India

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad: Fourth Quarter Financial Highlights - Bitget

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates - Yahoo Finance UK

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories Swings To Q4 Profit - Nasdaq

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad shares tumble as Q4 earnings miss expectations By Investing.com - Investing.com Australia

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results - TipRanks

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Laboratories (NYSE:BIO) Announces Quarterly Earnings Results - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Is Bio Rad Laboratories Inc. stock risky to hold now2025 Analyst Calls & Verified Momentum Watchlists - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - Business Wire

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad earnings on deck as estimates drift lower ahead of report By Investing.com - Investing.com South Africa

Feb 12, 2026
pulisher
Feb 12, 2026

Bio-Rad earnings on deck as estimates drift lower ahead of report - Investing.com UK

Feb 12, 2026
pulisher
Feb 11, 2026

Can Bio Rad Laboratories Inc. (BUW) stock sustain revenue momentumTrade Risk Summary & Daily Oversold Stock Bounce Ideas - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Dematic Automation Solution Drives Precision and Productivity for BIO-RAD Singapore - iTWire

Feb 10, 2026
pulisher
Feb 09, 2026

Bio-Rad receives AOAC international validation for EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network

Feb 09, 2026
pulisher
Feb 09, 2026

Medical Biosensors Market is expected to reach US$ 12.60 Billion - openPR.com

Feb 09, 2026
pulisher
Feb 07, 2026

Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

Bio-Rad EZ-Check Listeria Test Kits Receive AOAC Validation - Food Safety Magazine

Feb 06, 2026
pulisher
Feb 05, 2026

Multiplex Immunoassays Market to Reach US$ 6.90 Billion by 2033 - openPR.com

Feb 05, 2026
pulisher
Feb 05, 2026

Atlantic Union Bankshares Corp Purchases Shares of 4,099 Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

The Latest in ddPCR Technology - the-scientist.com

Feb 04, 2026
pulisher
Feb 04, 2026

PCR Technologies Market Is Going to Boom |• Thermo Fisher Scientific • Bio-Rad Laboratories - openPR.com

Feb 04, 2026
pulisher
Feb 03, 2026

Polymerase Chain Reaction Market Set for Rapid Growth and Trend - openPR.com

Feb 03, 2026
pulisher
Feb 02, 2026

United States Digital PCR Market to Reach at 7.4% CAGR by 2031; - openPR.com

Feb 02, 2026
pulisher
Feb 02, 2026

DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com

Feb 02, 2026
pulisher
Feb 02, 2026

Mawer Investment Management Ltd. Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Veritas Asset Management LLP Has $236.66 Million Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Feb 02, 2026

Bio Rad Laboratories Inc Stock (BIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$96.45
price up icon 1.33%
medical_devices STE
$248.35
price up icon 1.69%
$70.02
price up icon 7.59%
medical_devices PHG
$31.25
price down icon 0.51%
$80.34
price up icon 2.15%
medical_devices EW
$75.87
price down icon 0.75%
Cap:     |  Volume (24h):